NASH - Nonalcoholic Steatohepatitis Terminated Phase 3 Trials for Eltrombopag (DB06210)

IndicationStatusPhase
DBCOND0088313 (NASH - Nonalcoholic Steatohepatitis)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00678587Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive ProceduresTreatment